Matches in SemOpenAlex for { <https://semopenalex.org/work/W4327712504> ?p ?o ?g. }
Showing items 1 to 87 of
87
with 100 items per page.
- W4327712504 abstract "Abstract Purpose Recurrent glioblastoma (GBM) is challenging, and effective treatment options after bevacizumab failure are limited. Re-irradiation combined with bevacizumab has emerged as a potential therapeutic option for recurrent GBM patients who have failed bevacizumab treatment. This study aims to evaluate the efficacy of re-irradiation in patients with progressive GBM refractory to bevacizumab monotherapy and explore the factors that may impact survival. Methods and materials This retrospective study enrolled 64 patients who developed a second progression after single-agent bevacizumab therapy. The patients were divided into two groups: 35 continued with bevacizumab alone (none-ReRT group), and 29 received bevacizumab and re-irradiation (ReRT group). The study measured overall survival time after bevacizumab failure (OST-BF) and after re-irradiation (OST-RT). Statistical tests were used to compare categorical variables, evaluate the difference in recurrence patterns between the two groups, and identify optimal cutoff points for re-irradiation volume. Results The Kaplan-Meier survival analysis revealed that the ReRT group had a significantly higher survival rate and longer median survival time than the none-ReRT group. The median OST-BF and OST-RT were 14.5 months and 8.8 months, respectively, for the ReRT group, while the OST-BF for the none-ReRT group was 3.9 months (p < 0.001). Cox univariate analysis for overall survival time after bevacizumab failure (OST-BF) identified KPS at bevacizumab failure, ORR, bevacizumab failure pattern, re-irradiation, and re-irradiation target volume as significant predictors of survival time after bevacizumab failure. The multivariable analysis found only the re-irradiation target volume to be significant for OST-RT. Conclusions The study suggests that re-irradiation combined with bevacizumab therapy may be a valuable treatment option for patients with recurrent GBM who have failed bevacizumab therapy. The re-irradiation target volume may be a valuable prognostic factor for these patients, with smaller target volumes associated with better survival outcomes. Further studies with larger sample sizes and prospective designs are necessary to confirm these results and determine the optimal treatment approach for these patients." @default.
- W4327712504 created "2023-03-18" @default.
- W4327712504 creator A5002338740 @default.
- W4327712504 creator A5020446670 @default.
- W4327712504 creator A5042288304 @default.
- W4327712504 creator A5058833097 @default.
- W4327712504 creator A5063438566 @default.
- W4327712504 creator A5065553292 @default.
- W4327712504 date "2023-03-17" @default.
- W4327712504 modified "2023-10-17" @default.
- W4327712504 title "Effect of re-irradiation at bevacizumab failure in recurrent glioblastoma: a comparative analysis with maintenance bevacizumab" @default.
- W4327712504 cites W1131275742 @default.
- W4327712504 cites W2026827454 @default.
- W4327712504 cites W2132697290 @default.
- W4327712504 cites W2154303411 @default.
- W4327712504 cites W2159314579 @default.
- W4327712504 cites W2165772224 @default.
- W4327712504 cites W2165860547 @default.
- W4327712504 cites W2272163797 @default.
- W4327712504 cites W2302516330 @default.
- W4327712504 cites W2436534309 @default.
- W4327712504 cites W2494549078 @default.
- W4327712504 cites W2618874742 @default.
- W4327712504 cites W2732147664 @default.
- W4327712504 cites W2765814211 @default.
- W4327712504 cites W2768388636 @default.
- W4327712504 cites W2778283729 @default.
- W4327712504 cites W2791378348 @default.
- W4327712504 cites W2793549603 @default.
- W4327712504 cites W2795921708 @default.
- W4327712504 cites W2892927588 @default.
- W4327712504 cites W2903289999 @default.
- W4327712504 cites W2904710333 @default.
- W4327712504 cites W3045066396 @default.
- W4327712504 cites W3096462332 @default.
- W4327712504 cites W3101467937 @default.
- W4327712504 cites W3201044190 @default.
- W4327712504 cites W4210260154 @default.
- W4327712504 cites W4296992803 @default.
- W4327712504 cites W4301595791 @default.
- W4327712504 cites W4306932084 @default.
- W4327712504 cites W4321258530 @default.
- W4327712504 cites W4321502467 @default.
- W4327712504 doi "https://doi.org/10.21203/rs.3.rs-2689382/v1" @default.
- W4327712504 hasPublicationYear "2023" @default.
- W4327712504 type Work @default.
- W4327712504 citedByCount "0" @default.
- W4327712504 crossrefType "posted-content" @default.
- W4327712504 hasAuthorship W4327712504A5002338740 @default.
- W4327712504 hasAuthorship W4327712504A5020446670 @default.
- W4327712504 hasAuthorship W4327712504A5042288304 @default.
- W4327712504 hasAuthorship W4327712504A5058833097 @default.
- W4327712504 hasAuthorship W4327712504A5063438566 @default.
- W4327712504 hasAuthorship W4327712504A5065553292 @default.
- W4327712504 hasBestOaLocation W43277125041 @default.
- W4327712504 hasConcept C10515644 @default.
- W4327712504 hasConcept C126322002 @default.
- W4327712504 hasConcept C141071460 @default.
- W4327712504 hasConcept C143998085 @default.
- W4327712504 hasConcept C2776694085 @default.
- W4327712504 hasConcept C2777802072 @default.
- W4327712504 hasConcept C50382708 @default.
- W4327712504 hasConcept C71924100 @default.
- W4327712504 hasConceptScore W4327712504C10515644 @default.
- W4327712504 hasConceptScore W4327712504C126322002 @default.
- W4327712504 hasConceptScore W4327712504C141071460 @default.
- W4327712504 hasConceptScore W4327712504C143998085 @default.
- W4327712504 hasConceptScore W4327712504C2776694085 @default.
- W4327712504 hasConceptScore W4327712504C2777802072 @default.
- W4327712504 hasConceptScore W4327712504C50382708 @default.
- W4327712504 hasConceptScore W4327712504C71924100 @default.
- W4327712504 hasLocation W43277125041 @default.
- W4327712504 hasOpenAccess W4327712504 @default.
- W4327712504 hasPrimaryLocation W43277125041 @default.
- W4327712504 hasRelatedWork W2046885256 @default.
- W4327712504 hasRelatedWork W2150311952 @default.
- W4327712504 hasRelatedWork W2401649272 @default.
- W4327712504 hasRelatedWork W2558534037 @default.
- W4327712504 hasRelatedWork W2893495784 @default.
- W4327712504 hasRelatedWork W2896492909 @default.
- W4327712504 hasRelatedWork W2970255569 @default.
- W4327712504 hasRelatedWork W3011827526 @default.
- W4327712504 hasRelatedWork W3041757410 @default.
- W4327712504 hasRelatedWork W4285594075 @default.
- W4327712504 isParatext "false" @default.
- W4327712504 isRetracted "false" @default.
- W4327712504 workType "article" @default.